Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2020-03-09 Regulatory Filings
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1477 characters) and contains the header 'RNS Number : 4951F'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. This is a general regulatory announcement that does not fit the specific categories like Earnings Release (ER), Annual Report (10-K), or Dividend Notice (DIV). Since it is a standard notification provided via the RNS service, the most appropriate classification is the general Regulatory Filings category.
2020-03-09 English
Appointment of Dr Karl Keegan
Board/Management Information Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing information via 'RNS, the news service of the London Stock Exchange.' The core content announces the 'Appointment of Dr Karl Keegan' as a Non-Executive Director. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter dictates the MANG classification over the general RNS fallback.
2020-02-18 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1497 characters) and contains an 'RNS Number' (RNS Number : 1165D), indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or CAP). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, MANG, or DIV, the most appropriate fallback category is Regulatory Filings (RNS).
2020-02-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1480 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' and an 'auction call extension' for a security, which is a routine operational update related to trading mechanisms. It does not contain detailed financial results (ER, IR, 10-K) or management changes (MANG). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIV, DIRS, or CAP, the most appropriate classification is the general regulatory filing category, RNS.
2020-02-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1497 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a direct, time-sensitive announcement disseminated via the London Stock Exchange's news service (RNS) that doesn't fit into the more specific categories (like DIRS, DIV, ER, etc.), the most appropriate classification is the general regulatory announcement fallback category.
2020-02-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1480 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for a security, which is a routine operational notice related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIV, DIRS, or MANG, the most appropriate classification is the general regulatory filing fallback category.
2020-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.